Mark Slomiany PhD MBA MPA

Mark Slomiany is a prominent figure in the healthcare advisory sector, currently serving as the Director of Advisory at Marwood Group. He holds multiple advanced degrees, including a PhD, MBA, and MPA. His professional background includes significant experience in healthcare and life sciences, with over 20 years in the field.

Professional Background

• Current Role: Director of Advisory at Marwood Group, where he leads various engagements related to pharmacy and healthcare strategy.
• Previous Experience:
  • Former faculty member in the Department of Cardiothoracic Surgery at New York University Langone Health.
  • Research associate at the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School.
  • Director of Market Access Health at Ipsos, a global market research firm.

Areas of Expertise

Slomiany's work focuses on several critical areas within healthcare:

• Pharmacological Interventions: He has contributed to discussions on the development and impact of weight-loss drugs and their integration into healthcare provider services.
• Artificial Intelligence in Healthcare: He explores the implications of AI on provider efficiency and patient care models.
• Regulatory and Legislative Analysis: His expertise includes understanding how federal and state policies affect healthcare reimbursement and business strategies.

Educational Background

Mark Slomiany has an educational foundation from prestigious institutions, including Harvard University, which underpins his extensive knowledge in healthcare policy and management.

In summary, Mark Slomiany is a well-respected leader in healthcare advisory services, known for his analytical insights into drug development, AI integration in healthcare, and regulatory dynamics impacting the industry.